Reversal of Paclitaxel Resistance in Epithelial Ovarian Carcinoma Cells by a MUC1 Aptamer-let-7i Chimera

siRNA-Aptamer Chimeras on Nanoparticles: Preserving Targeting Functionality for Effective Gene Silencing

(2011) Vaishali Bagalkot et al.   ACS Nano

Anti-MUC1 antibody inhibits EGF receptor signaling in cancer cells

(2011) Akinori Hisatsune et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

miR-203 reverses chemoresistance in p53-mutated colon cancer cells through downregulation of Akt2 expression

(2011) Jian Li et al.   CANCER LETTERS

Solution structure of a truncated anti-MUC1 DNA aptamer determined by mesoscale modeling and NMR

(2011) Meriem Baouendi et al.   FEBS Journal

Prostate-targeted radiosensitization via aptamer-shRNA chimeras in human tumor xenografts

(2011) Xiaohua Ni et al.   JOURNAL OF CLINICAL INVESTIGATION

Novel Aptamer-Nanoparticle Bioconjugates Enhances Delivery of Anticancer Drug to MUC1-Positive Cancer Cells In Vitro

(2011) Chenchen Yu et al.   PLoS One

Intracellular clusterin negatively regulates ovarian chemoresistance: compromised expression sensitizes ovarian cancer cells to paclitaxel

(2011) Mohamed Kamel Hassan et al.   TUMOR BIOLOGY

Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancer

(2010) Konstantin J. Dedes et al.   EUROPEAN JOURNAL OF CANCER

Study of the Molecular Recognition of Aptamers Selected through Ovarian Cancer Cell-SELEX

(2010) Dimitri Van Simaeys et al.   PLoS One

MicroRNA Microarray Identifies Let-7i as a Novel Biomarker and Therapeutic Target in Human Epithelial Ovarian Cancer

(2008) N. Yang et al.   CANCER RESEARCH